Abstract:In this study, the anti-inflammatory effects of the methanolic extract (TE) of Plumeria obtusa L. (aerial parts) and its fractions were evaluated in vitro, and active fraction was evaluated in vivo. Among tested extracts, dichloromethane fraction (DCM-F) exhibited the strongest inhibition of lipopolysaccharide (LPS)-induced nitric oxide (NO) in RAW 264.7 macrophages. The effect of DCM-F on LPS-induced acute lung injury (ALI) in mice was studied. The animals were divided into five groups (n = 7) randomly; Gp I: negative control, GP II: positive control (LPS group), GP III: standard (dexamethasone, 2 mg/kg b.wt), GP IV and V: DCM-F (100 mg/kg), and DEM-F (200 mg/kg), respectively. DCM-F at a dose of 200 mg/kg suppressed the ability of LPS to increase the levels of nitric oxide synthase (iNOS), NO, tumor necrosis factor-α (TNF-α), and interleukin 6 (IL-6), as measured by ELISA. In addition, the expression of cyclooxygenase-2 (COX-2) was reduced (determined by immunohistochemistry) and the level of malondialdehyde (MDA) was decreased while that of catalase was restored to the normal values. Furthermore, the histopathological scores of inflammation induced by LPS were reduced. Twenty-two compounds were tentatively identified in DCM-F using LC/ESI-QToF with iridoids, phenolic derivatives and flavonoids as major constituents. Identified compounds were subjected to two different molecular docking processes against iNOS and prostaglandin E synthase-1 target receptors. Notably, protoplumericin A and 13-O-coumaroyl plumeride were the most promising members compared to the co-crystallized inhibitor in each case. These findings suggested that DCM-F attenuates the LPS-induced ALI in experimental animals through its anti-inflammatory and antioxidant potential.

Plumeriapropionics A–E, Carboxyl-Substituted Phenylpropionic Acid Derivatives with Anti-Inflammatory Activity from Plumeria rubra L.

Pepluane and Paraliane Diterpenoids from Euphorbia Peplus with Potential Anti-inflammatory Activity

Bioactive Constituents From The Aerial Parts Of Pluchea Indica Less

Bioactive 5/5/5/6 Four‐ring System Iridoids from Plumeria alba L.

Spirocyclic iridoid alkaloids from Plumeria rubra

Phenolic Acids Derivatives from Meehania Fargesii with Anti‐inflammation Effects

The Antioxidant and Xanthine Oxidase Inhibitory Activity of Plumeria rubra Flowers

Sesquiterpenoids from Chloranthus Henryi and Their Anti‐neuroinflammatory Activities

New phenylpropanoid derivatives from the fruits of Xanthium sibiricum and their anti-inflammatory activity.

Design, Synthesis, and Biological Activity of Tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine Derivatives as Anti-Inflammatory Agents

Methyl 2-Naphthoates with Anti-Inflammatory Activity from Morinda Officinalis

Anti-inflammatory Dimeric 2-(2-phenylethyl)chromones from the Resinous Wood of Aquilaria Sinensis

New Anti-Inflammatory Aromatic Components from Antrodia camphorata

Bioactive fraction from Plumeria obtusa L. attenuates LPS-induced acute lung injury in mice and inflammation in RAW 264.7 macrophages: LC/QToF-MS and molecular docking

Novel Phenylpropanoid Derivative from Euploca procumbens (Mill.) Diane & Hilger with Potential Anti-Inflammatory Activity

Anti-inflammatory 5,6,7,8-Tetrahydro-2-(2-phenylethyl) Chromone Derivatives from the Stems of Aquilaria Sinensis

N-alkylamides from Litsea Cubeba (lour.) Pers. with Potential Anti-Inflammatory Activity

New Aniline Derivatives from the Volva of Phallus Rubrovolvatus and Their Anti-Inflammatory Activity

Phenylpropanoid Derivatives from the Tuber of Asparagus cochinchinensis with Anti-Inflammatory Activities

Four alkaloids from Portulaca oleracea L. and their anti-inflammatory

Anti-Inflammatory Prenylated Phenylpropenols and Coumarin Derivatives from Murraya Exotica.